Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a monoclonal antibody therapy for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED